This guide provides evidence-based recommendations for patients and clinicians navigating this common clinical scenario
Nearly all the experts I spoke with said that we needed more research
You might need more time for your body to adjust or to move up to a higher dose of semaglutide before you feel the difference
A health warning on repurposed drugs None of the above should be read to suggest and it is not DW's recommendation that anyone use GLP-1 agonists, or any other drug, to treat any "off label"/non-approved condition, without personal, professional medical advice
Several clinical programs are already exploring these combination approaches, and positive Phase II data from combination regimens could substantially expand the addressable market by increasing the percentage of patients for whom treatment is recommended and broadening insurance coverage frameworks
Please verify with the individual plan sponsors for coverage and updated information